Product Description
Technical Specification
- Minimum Order Quantity : 1 Vial
- Compostion : Bortezomib (2mg)
- Dose : As per doctor concern
- Storage : Store below 30 DegreeC
- Side Effect : NA
- Directions for Use : As per doctor concern
- Form : Injection
- Prescription/Non prescription : Prescription
Effective Cancer Therapy for Serious ConditionsMyezom 2 mg Injection is specifically designed for patients diagnosed with multiple myeloma and mantle cell lymphoma. Its active ingredient, Bortezomib, helps impede the growth and survival of malignant cells, providing significant benefit in cancer management when used as directed within prescribed chemotherapeutic protocols.
Simplified Reconstitution and AdministrationThe lyophilized powder is reconstituted with sterile 0.9% sodium chloride before use and is suitable for intravenous or subcutaneous injection. This makes Myezom adaptable to various hospital and clinical settings, ensuring accurate dosing and maximizing effectiveness for patients.
High-Quality Standards and Reliable PackagingEach vial of Myezom delivers a precise 2 mg dose, ensuring quality and safety. The product is stable for up to 2 years when stored properly, and comes as a sterile, single-dose vial-ideal for dealer, distributor, and healthcare provider needs across India.
FAQ's of Myezom 2 mg Injection:
Q: How should Myezom 2 mg Injection be prepared and administered?
A: Myezom 2 mg Injection should be reconstituted with sterile 0.9% sodium chloride to dissolve the lyophilized powder, and must be administered intravenously or subcutaneously by a qualified healthcare professional.
Q: What is the main benefit of using Myezom for cancer patients?
A: Myezom is effective in treating multiple myeloma and mantle cell lymphoma by targeting and inhibiting the growth of cancer cells, helping to control disease progression and improving therapy outcomes.
Q: When is Myezom contraindicated?
A: Myezom should not be used in patients with known hypersensitivity to Bortezomib, boron, or any of the formulation's excipients, as adverse reactions may occur.
Q: What are the most commonly experienced side effects with Myezom?
A: Common side effects include nausea, fatigue, diarrhea, and peripheral neuropathy. Any persistent or severe symptoms should be promptly reported to a healthcare professional.
Q: Where should Myezom vials be stored before use?
A: Store Myezom vials in a cool, dry place, away from direct sunlight and moisture, to maintain stability and effectiveness throughout its 2-year shelf life.
Q: What precautions should be observed during the usage of Myezom?
A: Myezom must be administered as a single-dose under medical supervision, with careful observation for adverse reactions, and only by prescription to ensure safety and proper therapeutic management.